載入...
Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy
Lymphatic metastasis is a major determinant of the outcome of resected pancreatic cancer. Gemcitabine-based adjuvant chemotherapy can improve the outcome of resected pancreatic cancer. However, the efficacy of gemcitabine against pancreatic cancer stratified by nodal involvement is unclear. In this...
Na minha lista:
| 發表在: | Cancer Control |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7153189/ https://ncbi.nlm.nih.gov/pubmed/32268796 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1073274820915947 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|